R1	Has_value Arg1:T4 Arg2:T5	
R2	Subsumes Arg1:T3 Arg2:T4	
R3	Has_value Arg1:T3 Arg2:T6	
*	OR T9 T10
R4	Subsumes Arg1:T11 Arg2:T9	
R5	Subsumes Arg1:T14 Arg2:T13	
*	OR T17 T15
R6	Subsumes Arg1:T17 Arg2:T16	
R7	Has_value Arg1:T20 Arg2:T21	
R8	AND Arg1:T19 Arg2:T20	
R9	Has_temporal Arg1:T22 Arg2:T23	
R11	Has_qualifier Arg1:T24 Arg2:T26	
R12	Has_mood Arg1:T28 Arg2:T27	
*	OR T2 T28
*	OR T29 T30
R13	Has_temporal Arg1:T2 Arg2:T29	
R10	multi Arg1:T24 Arg2:T25	
T1	Parsing_Error 0 9	Patients:
T3	Measurement 110 128	post-void residual
T4	Measurement 141 144	PVR
T5	Value 145 152	> 100cc
T6	Value 101 109	elevated
T7	Condition 162 180	bleeding condition
T8	Procedure 187 209	anti-coagulant therapy
T9	Condition 240 243	HIV
T10	Condition 245 253	lymphoma
T11	Observation 216 233	immunosuppression
T13	Condition 261 279	multiple sclerosis
T14	Condition 289 321	progressive neurological disease
T15	Condition 351 369	systemic infection
T16	Condition 381 404	urinary tract infection
T17	Condition 342 347;360 369	local infection
T19	Condition 423 453	intrinsic sphincter deficiency
T20	Measurement 470 503	maximal urethral closure pressure
T21	Value 507 517	<20 cm H2O
T22	Procedure 528 546	sub-urethral sling
T23	Temporal 519 527	Previous
T24	Condition 560 587	overactive bladder symptoms
T26	Qualifier 548 559	Predominant
T2	Condition 19 27	pregnant
T27	Mood 31 49	planning to become
T28	Condition 50 58	pregnant
T29	Temporal 59 75	during the study
T30	Temporal 79 92	in the future
T25	Condition 560 578	overactive bladder
